Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis

Jeremy Bjelajac(Stanford University), Adrià Cañellas‐Socias(Cancer Prevention Institute of California), Preeti Nehra(Stanford University), Kevin Reynolds(Stanford University), Meena Malipatlolla(Stanford University), Naiara Martínez-Vélez(Stanford University), Diane C. Manjarrez(Stanford University), Katie Ho(Stanford University), Peng Xu(Stanford University), Jennifer L. Hamad(Stanford University), Sean A. Yamada-Hunter(Parker Institute for Cancer Immunotherapy), Louai Labanieh(Icahn School of Medicine at Mount Sinai), Elena Sotillo(Cancer Prevention Institute of California), Crystal L. Mackall(Stanford University)
Cited by 0Open Access
Full Text

Abstract

We sought to endow T cell autonomous regulation of cell surface protein expression by exploiting the conditional proteolytic activity of ADAM17 following T cell activation. Screening of canonical ADAM17 substrates yielded a minimal 15-aa CD62L-derived motif that confers rapid and reversible cleavage of a receptor following T cell activation-termed activation-induced release (AIR). Embedding AIR into tonic-signaling CARs reduced basal CAR expression proportional to the degree of tonic signaling induced, curtailing exhaustion and improving antitumor potency. In non-tonic signaling CARs, AIR decreased activation-induced cell death and enhanced T cell expansion after stimulation. AIR's modularity supports higher-order logic-gating; AIR-regulated peptide masks enable antigen-dependent unmasking of an EGFR-targeting CAR. Finally, CRISPR knockin of AIR into endogenous FAS or TGFBR2 endowed them with activation-induced shedding, which enhanced tumor clearance while preserving signaling in non-activating conditions. AIR is a compact switch that provides fast, autonomous regulation of surface proteins for next-generation cell therapies.


Related Papers

No related papers found

Powered by citation graph analysis